DMAC
DiaMedica Therapeutics Inc
NASDAQ: DMAC · HEALTHCARE · BIOTECHNOLOGY
$6.05
+1.51% today
Updated 2026-04-30
Market cap
$341.08M
P/E ratio
—
P/S ratio
66.68x
EPS (TTM)
$-0.70
Dividend yield
—
52W range
$3 – $10
Volume
0.2M
DiaMedica Therapeutics Inc (DMAC) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $25737.00 | $160623.00 | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $500000.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | +524.1% | -100.0% | — | — | — | — | — | — | — | — | — | — | -100.0% | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $4459.00 | $2211.00 | $4000.00 | $0.00 | $21000.00 | $21000.00 | $24000.00 | $25000.00 | $30000.00 | $39000.00 | — |
| Gross profit | $25737.00 | $160623.00 | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-4459.00 | $-2211.00 | $-4000.00 | $500000.00 | $-21000.00 | $-21000.00 | $-24000.00 | $-25000.00 | $-30000.00 | $-39000.00 | — |
| Gross margin | 100.0% | 100.0% | — | — | — | — | — | — | — | — | — | — | 100.0% | — | — | — | — | — | — | — |
| R&D | $617257.00 | $1.07M | $1.04M | $1.37M | $803984.00 | $2.33M | $5.21M | $3.78M | $3.71M | $886073.00 | $1.76M | $3.21M | $4.52M | $7.90M | $8.21M | $8.77M | $7.84M | $13.11M | $19.06M | $24.61M |
| SG&A | — | — | $618539.00 | $1.00M | $1.30M | $2.08M | $2.53M | $2.54M | $1.12M | $423354.00 | $718045.00 | $1.31M | $2.74M | $3.69M | $4.49M | $4.88M | $6.06M | $7.96M | $7.43M | $9.78M |
| Operating income | $-787210.00 | $-2.31M | $-1.69M | $-2.40M | $-3.84M | $-6.71M | $-10.11M | $-7.43M | $-4.83M | $-1.31M | $-2.48M | $-4.52M | $-6.76M | $-11.59M | $-12.70M | $-13.65M | $-14.00M | $-21.27M | $-26.68M | $-34.40M |
| Operating margin | -3058.7% | -1438.0% | — | — | — | — | — | — | — | — | — | — | -1352.2% | — | — | — | — | — | — | — |
| EBITDA | $-783891.00 | $-2.29M | $-2.34M | $-2.27M | $-3.32M | $-4.51M | $-7.70M | $-6.51M | $-5.01M | $-1.50M | $-2.15M | $-4.26M | $-5.64M | $-11.57M | $-12.68M | $-13.62M | $-13.98M | $-21.24M | $-26.64M | $-34.35M |
| EBITDA margin | -3045.8% | -1426.6% | — | — | — | — | — | — | — | — | — | — | -1127.8% | — | — | — | — | — | — | — |
| EBIT | $-787210.00 | $-2.31M | $-2.36M | $-2.30M | $-4.99M | $-6.81M | $-10.06M | $-7.62M | $-5.02M | $-1.50M | $-2.15M | $-4.26M | $-5.65M | $-11.59M | $-12.70M | $-13.65M | $-14.00M | $-21.27M | $-26.68M | $-34.40M |
| Interest expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $12568.00 | $2715.00 | $7729.00 | $0.00 | $43955.00 | $48375.00 | $0.00 | $0.00 | $119000.00 | $229000.00 | $82000.00 | $353000.00 | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-778018.00 | $-2.33M | $-1.85M | $-2.44M | $-4.27M | $-6.61M | $-10.05M | $-7.41M | $-4.82M | $-1.44M | $-2.22M | $-4.26M | $-5.73M | $-10.65M | $-12.29M | $-13.59M | $-13.68M | $-19.38M | $-24.44M | $-32.77M |
| Net income growth (YoY) | — | -199.9% | +20.6% | -31.4% | -75.2% | -54.9% | -52.1% | +26.3% | +35.0% | +70.1% | -54.1% | -91.6% | -34.6% | -85.7% | -15.4% | -10.6% | -0.6% | -41.7% | -26.1% | -34.0% |
| Profit margin | -3023.0% | -1452.8% | — | — | — | — | — | — | — | — | — | — | -1146.8% | — | — | — | — | — | — | — |